DNA X, Inc.
SONM· Nasdaq
SONMDNA X, Inc.
Filed May 14, 2020 · 10-Q · 44 days after period end · 0001564590-20-025509
| Metric | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|
| Revenue | $12.71M | $26.48M | $18.19M |
| Net Income | -$9.96M | -$6.21M | -$5.07M |
| EPS Diluted | -$0.48 | -$0.32 | -$7.77 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DNA X, Inc. · CIK 1178697 · Engraved from SEC EDGAR
ended Mar 31, 2020 · filed May 14, 2020 · 44 d after period end
